TP53 Mutation Carriers with Breast Cancer Face Elevated Risk of Sarcoma Post-Radiotherapy

TOPLINE:
Patients with breast cancer carrying TP53 pathogenic variants face an 8.8% cumulative risk of developing sarcoma within 15 years…